Chengzheng Wang

1 article listing Chengzheng Wang in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Neoadjuvant anti-HER2 antibody-drug conjugate SHR-A1811 in Hormone Receptor-positive, HER2-low Breast Cancer: A Phase 2 Clinical Trial (HELEN-015) Nature Communications